Deven Chauhan

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

Vincent Meininger, Angela Genge, Leonard H van den Berg et al. · The Lancet Neurology · 2017 · 82 citations · Full text

Amyotrophic Lateral Sclerosis, Neurological Disorder, Clinical Neurology +4

A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis

Sarah Acaster, R Perard, Deven Chauhan et al. · BMC Health Services Research · 2013 · 34 citations · Full text

Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials

Ioannis Parodis, Julius Lindblom, Roger A. Levy et al. · The Lancet Rheumatology · 2024 · 22 citations

Exploration of the difference in results of economic submissions to the National Institute of Clinical Excellence by manufacturers and assessment groups

Deven Chauhan, Alec Miners, Alastair J. Fischer · International Journal of Technology Assessment in Health Care · 2007 · 20 citations

Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks

Binod Neupane, Pragya Shukla, Mahmoud Slim et al. · Lupus Science & Medicine · 2023 · 20 citations · Full text